文献速递细胞病理与分子病理胸部病理

Aspyre Lung(组织)检测对细胞学标本进行简化基因组分析的可行性

Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue).
PubMed 文献 · Cancer Cytopathol · 2026-01-01

该研究用Aspyre Clinical Test for Lung(Tissue)检测85份来自细针穿刺冲洗液或胸腔积液的非小细胞肺癌核酸样本,并与Oncomine Precision Assay Genexus法对照。

要点

  • 与对照方法结果完全一致,阳性与阴性符合率均为100%。

核心结论

  • Aspyre Clinical Test for Lung在细针穿刺冲洗液和胸腔积液来源的样本上运行有效。
  • 使用此类细胞学标本进行生物标志物检测可简化基因组分析并保留珍贵组织标本。

研究设计与样本

  • 研究纳入85份非小细胞肺癌DNA或总核酸样本,来源于45份细针穿刺冲洗液或胸腔积液样本。
  • 样本来自宾夕法尼亚大学医院存档,在Biofidelity的CAP/CLIA实验室用Aspyre Clinical Test for Lung(Tissue)检测。
  • 所有样本此前已用Oncomine Precision Assay Genexus法(正交参考方法)表征。

主要发现

  • 所有结果在两种方法间一致,阳性百分符合率和阴性百分符合率均为100%。

临床怎么用

  • 对细针穿刺冲洗液和胸腔积液等细胞学标本可采用Aspyre Lung进行简化基因组分析。
  • 该策略可在获得生物标志物结果的同时保留珍贵组织标本,可能减少额外侵入性操作的需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Testing patients with non-small cell lung cancer for actionable variants is essential for guiding treatment decisions in accordance with established cancer care guidelines, though limited quantity and quality of tumor tissue often leaves insufficient material for comprehensive testing. Cytopathology specimens obtained through minimally invasive techniques are a potential source of diagnostic material for genomic profiling, though typically challenging to analyze. METHODS: A total of 85 DNA or total nucleic acid non-small cell lung cancer samples derived from 45 fine-needle aspirate rinse or pleural fluid samples from the Hospital of the University of Pennsylvania archive were tested using the Aspyre Clinical Test for Lung (Tissue) in Biofidelity's CAP/CLIA laboratory. All samples were previously characterized by the Oncomine Precision Assay Genexus assay (the orthogonal reference method). RESULTS: Eighty-four of 85 passed Aspyre Lung quality control, one failed. Twenty-six samples were positive for variants in the Aspyre Lung panel: 17 for single nucleotide variants (KRAS, EGFR), three for EGFR insertions/deletions, two for MET exon 14 skipping, and five for gene fusions. Eighty-two of 85 samples were run at standard input levels; three of 85 were run at low input but passed Aspyre Lung controls and include one EGFR exon 20 insertion variant-positive. All results were concordant between methods. Positive Percent Agreement and Negative Percent Agreement were 100%. CONCLUSIONS: Aspyre Clinical Test for Lung performs effectively on samples derived from fine needle aspirate rinses and pleural fluid. Using these cytology-based specimens for biomarker testing enables pathologists to perform simplified genomic profiling while preserving valuable tissue specimens, potentially reducing the need for additional invasive procedures.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Gentile C, Herlihy SE, Shapiro E, et al. Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue). Cancer Cytopathol. 2026. PMID: 42252866. doi:10.1002/cncy.70121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。